This study comprehensively utilized toad hearts and myocardial cell models to explore the effects of acute lead exposure on myocardial contractile function and the therapeutic effect of alpha lipoic acid (ALA). The results showed that lead acetate (PbAc) dose dependently inhibited the contractile function of toad hearts. Acute treatment with 50, 150, and 450 mM PbAc reduced the amplitude of heart contraction to 92.8%, 78.0%, and 69.7% of the control before medication (P<0.01), respectively, and reduced heart rate to 92.4%, 92.5%, and 54.9% of the control before medication (P<0.05). After treatment with a middle concentration of PbAc (150 mM) for 24 hours, the cell viability of H9c2 decreased to 71.9% of the control group (P<0.05). Compared with the lead exposure group, ALA at a concentration of 10 μM significantly improved cardiac contractile function, increasing the amplitude of cardiac contractions and heart rate to 109.4% and 134.2% of the control, respectively (P<0.05). Correspondingly, ALA at a concentration of 20 μM increased the cell viability of H9c2 to 112.6% of the control group (P<0.05). This study indicates that PbAc can significantly inhibit myocardial contractility and reduce cell viability, while ALA can antagonize lead induced myocardial injury and has significant cardioprotective potential.
| Published in | American Journal of Bioscience and Bioengineering (Volume 13, Issue 6) |
| DOI | 10.11648/j.bio.20251306.11 |
| Page(s) | 106-110 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Lead Exposure, Myocardial Cells, Cardiac Contractility, Heart Rate, Alpha Lipoic Acid
| [1] | Mandal G., Mandal A., Chakraborty A. The toxic effect of lead on human health. Human Biology and Public Health. 2023, 3. |
| [2] | Babiker F., Al-Kouh A., Kilarkaje N. Lead exposure induces oxidative stress, apoptosis, and attenuates protection of cardiac myocytes against ischemia-reperfusion injury. Drug and Chemical Toxicology. 2019, 42(2), 147-156. |
| [3] | Chen Z., Huo X., Chen G., et al. Lead (Pb) exposure and heart failure risk. Environmental Science and Pollution Research. 2021, 28(23), 28833-28847. |
| [4] | Gholami S., Badalzadeh R., Alihemmati A. Alpha-lipoic acid enhances ischemic postconditioning-mediated improvement of myocardial infarction and apoptosis in diabetic rats with ischemia/reperfusion injury. Canadian Journal of Physiology and Pharmacology. 2023, 101(12), 682-691. |
| [5] | Karakulak U., Yilmaz O., Tutkun E., et al. Comprehensive Electrocardiographic Analysis of Lead Exposed Workers: An Arrhythmic Risk Assessment Study. Annals of Noninvasive Electrocardiology. 2017, 22(2), 9. |
| [6] | Tripathi A., Ray A., Mishra S., et al. Molecular and Therapeutic Insights of Alpha-Lipoic Acid as a Potential Molecule for Disease Prevention. Revista Brasileira De Farmacognosia-Brazilian Journal of Pharmacognosy. 2023, 33(2), 272-287. |
| [7] | Yao Y., Li R., Ma Y., et al. α-Lipoic acid increases tolerance of cardiomyoblasts to glucose/glucose oxidase-induced injury via ROS-dependent ERK1/2 activation. Biochimica Et Biophysica Acta-Molecular Cell Research. 2012, 1823(4), 920-929. |
| [8] | Shen C., Chen X., Cao Y., et al. Alpha-lipoic Acid Protects Against Chronic Alcohol Consumption-induced Cardiac Damage by the Aldehyde Dehydrogenase 2-associated PINK/Parkin Pathway. Journal of Cardiovascular Pharmacology. 2023, 82(5), 407-418. |
| [9] | Hagen T., Ingersoll R., Lykkesfeldt J., et al. (R<)-α-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. Faseb Journal. 1999, 13(2), 411-418. |
| [10] | Navari-Izzo F., Quartacci M., Sgherri C. Lipoic acid: a unique antioxidant in the detoxification of activated oxygen species. Plant Physiology and Biochemistry. 2002, 40(6-8), 463-470. |
| [11] | Wang Y., Jiang S., He Y., et al. Advances in α-Lipoic Acid for Disease Prevention: Mechanisms and Therapeutic Insights. Molecules. 2025, 30(9), 30. |
| [12] | Vafaee F., Derakhshani M., Rahbardar M., et al. Alpha-lipoic acid, as an effective agent against toxic elements: a review. Naunyn-Schmiedebergs Archives of Pharmacology. 2025, 398(4), 3345-3372. |
| [13] | Tsai M., Huang S., Chen S., et al. Alpha-lipoic acid ameliorates influenza A virus caused acute pneumonia though enhancement of anti-viral T cell immunity and suppression of macrophage activation by inhibiting ERK1/2 signaling pathway. Journal of Functional Foods. 2024,116, 14. |
| [14] | Elsayed O., Wakeel L., Saleh M., et al. The impact of alpha lipoic acid administration on oxidative stress markers and occurrence of no-reflow phenomenon in post myocardial infarction patients. Future Journal of Pharmaceutical Sciences. 2025, 11(1), 13. |
| [15] | Shahid A., Nasir K., Bhatia M. Therapeutic Potential of Alpha-Lipoic Acid: Unraveling Its Role in Oxidative Stress and Inflammatory Conditions. Current Issues in Molecular Biology. 2025, 47(5), 16. |
| [16] | Superti F., Russo R. Alpha-Lipoic Acid: Biological Mechanisms and Health Benefits. Antioxidants. 2024, 13(10), 28. |
APA Style
Zhou, Z., Tang, Z., Dai, Z., Xu, S., Ge, Y., et al. (2025). Acute Lead Exposure Weakens Myocardial Contractile Function and the Therapeutic Effect of Alpha Lipoic Acid. American Journal of Bioscience and Bioengineering, 13(6), 106-110. https://doi.org/10.11648/j.bio.20251306.11
ACS Style
Zhou, Z.; Tang, Z.; Dai, Z.; Xu, S.; Ge, Y., et al. Acute Lead Exposure Weakens Myocardial Contractile Function and the Therapeutic Effect of Alpha Lipoic Acid. Am. J. BioSci. Bioeng. 2025, 13(6), 106-110. doi: 10.11648/j.bio.20251306.11
@article{10.11648/j.bio.20251306.11,
author = {Zhengyi Zhou and Zhuo Tang and Zihao Dai and Shuhe Xu and Yujie Ge and Yuemin Ding and Xiong Zhang},
title = {Acute Lead Exposure Weakens Myocardial Contractile Function and the Therapeutic Effect of Alpha Lipoic Acid
},
journal = {American Journal of Bioscience and Bioengineering},
volume = {13},
number = {6},
pages = {106-110},
doi = {10.11648/j.bio.20251306.11},
url = {https://doi.org/10.11648/j.bio.20251306.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.bio.20251306.11},
abstract = {This study comprehensively utilized toad hearts and myocardial cell models to explore the effects of acute lead exposure on myocardial contractile function and the therapeutic effect of alpha lipoic acid (ALA). The results showed that lead acetate (PbAc) dose dependently inhibited the contractile function of toad hearts. Acute treatment with 50, 150, and 450 mM PbAc reduced the amplitude of heart contraction to 92.8%, 78.0%, and 69.7% of the control before medication (PPPPP<0.05). This study indicates that PbAc can significantly inhibit myocardial contractility and reduce cell viability, while ALA can antagonize lead induced myocardial injury and has significant cardioprotective potential.
},
year = {2025}
}
TY - JOUR T1 - Acute Lead Exposure Weakens Myocardial Contractile Function and the Therapeutic Effect of Alpha Lipoic Acid AU - Zhengyi Zhou AU - Zhuo Tang AU - Zihao Dai AU - Shuhe Xu AU - Yujie Ge AU - Yuemin Ding AU - Xiong Zhang Y1 - 2025/11/22 PY - 2025 N1 - https://doi.org/10.11648/j.bio.20251306.11 DO - 10.11648/j.bio.20251306.11 T2 - American Journal of Bioscience and Bioengineering JF - American Journal of Bioscience and Bioengineering JO - American Journal of Bioscience and Bioengineering SP - 106 EP - 110 PB - Science Publishing Group SN - 2328-5893 UR - https://doi.org/10.11648/j.bio.20251306.11 AB - This study comprehensively utilized toad hearts and myocardial cell models to explore the effects of acute lead exposure on myocardial contractile function and the therapeutic effect of alpha lipoic acid (ALA). The results showed that lead acetate (PbAc) dose dependently inhibited the contractile function of toad hearts. Acute treatment with 50, 150, and 450 mM PbAc reduced the amplitude of heart contraction to 92.8%, 78.0%, and 69.7% of the control before medication (PPPPP<0.05). This study indicates that PbAc can significantly inhibit myocardial contractility and reduce cell viability, while ALA can antagonize lead induced myocardial injury and has significant cardioprotective potential. VL - 13 IS - 6 ER -